News

Article

Why Pharmacopoeia Compliance Is Difficult–An End-to-End Compendial Framework (PDF)

Author(s):

J. Mark Wiggins,Joseph A. Albanese

This article provides an end-to-end compendial framework to understand why compliance with pharmacopoeia standards is challenging.

External Link - PharmTech_2019-09_PharmacopeiaCompendia_ProblemStatement.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Blockchain for transparent supply chain tracking | Image Credit: ©Andrey -stock.adobe.com
September 3rd 2025

Keys to Navigating the Complex Drug Supply Chain

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
September 3rd 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com
September 3rd 2025

Effectively Using Contamination Control Strategies

Michelle Heiter Susan J. Schniepp
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
September 3rd 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
September 3rd 2025

Mislabeling Leads to Cyclobenzaprine Hydrochloride Recall

Susan Haigney
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
September 3rd 2025

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

Patrick Falvey Georgia Sloboda Sarah DeDonder Lauren Schoukroun-Barnes
© 2025 MJH Life Sciences

All rights reserved.